Byetta Uses
Links shared publicly online about this topic
Byetta Injection - TuDiabetes
tudiabetes.org — “Hi - I am new to using Byetta, 5mcg. My last A1C was 5.7 with no meds and my Endo put me on Byetta and Metformin. I wanted aggressive treatment. I am 115 lbs (5'6 ), T2 (Not LADA or 1.5 but genetic) and find it using the Byetta needles kinda painful. I usually inject around the belly area using the smallest needle which I think is 33 or 31 gauge. It hurts especially when I click the pen all the way. Is there a less painful way to inject? I inject at a 45 degree angle and have tried various parts” View full resource at tudiabetes.org
Most Recently Shared on May 5, 2010 at 11:02 pm By:
#byetta: Byetta Injection: Hi - I am new to using Byetta, 5mcg. Â My last A1C was 5.7 with no meds and my ... http://bit.ly/9YGrmq #diabetes
MediGuard - Byetta View
mediguard.org — “MediGuard - Byetta View” View full resource at mediguard.org
Most Recently Shared on November 13, 2010 at 6:17 pm By:
More than 54% of #byetta users are aged 45-60 ... http://tinyurl.com/yhnzpkc
Expanded approval for Byetta; but also renal warning
theheart.org — “The FDA has issued a warning about exenatide the same day the agency approved its first-line use along with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.” View full resource at theheart.org
Most Recently Shared on November 3, 2009 at 6:41 pm By:
heartwire: FDA expands exenatide use; warns of renal-failure risk http://bit.ly/O9Drq
Byetta FDA approved for extended use in Type 2 diabetes | the diabetes resource
thediabetesresource.com — “Byetta FDA approved for extended use in Type 2 diabetes | the diabetes resource” View full resource at thediabetesresource.com
Most Recently Shared on October 26, 2011 at 10:27 pm By:
Byetta FDA approved for extended use in Type 2 diabetes: http://t.co/RE8WmQCP
Is Januvia more effective than Byetta? - Medpedia
medpedia.com — “3 Answers. One (Januvia) is more convenient to use than the injectable Byetta. Hence my question.” View full resource at medpedia.com
Most Recently Shared on December 1, 2009 at 12:47 am By:
"Is Januvia more effective than Byetta?" #diabetes http://bit.ly/5PUfl1
Byetta for Type 2 Diabetes - Exenatide and Diabetes
diabetes.about.com — “Byetta is the first of a new class of drugs available for Type 2 diabetes management. It's not used for Type 1. It's been on the market for about a year. It is meant to be a supplemental drug, used in conjunction with Metformin or sulfonylureas or a combination of both to help improve glycemic control in people who have had trouble maintaining good blood glucose levels.” View full resource at diabetes.about.com
Most Recently Shared on May 29, 2010 at 2:28 pm By:
Byetta: Byetta is the first of a new class of drugs available for Type 2 diabetes management. It's not used for Ty... http://bit.ly/dgZEkR
Byetta Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
drugs.com — “Byetta (exenatide) is used to treat type 2 diabetes. Includes Byetta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 3, 2009 at 12:18 am By:
Byetta Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes - http://bit.ly/q10EZ
Byetta Pen Drips - TuDiabetes
tudiabetes.org — “I am new to TuDiabetes. I have been on Metformin for a few years & last December my Dr put me on Byetta. I have lost some weight but am kinda at a holding point. I have a question. When I take my Byetta injection, I have noticed that there is Byetta slowly dripping from the needle. I used to never see this but with this pen I have. Do you think it may just be the pen & do you think I am getting the medicine? Sometimes I feel like it curbs my appetite & other times it doesnt. Has anyo” View full resource at tudiabetes.org
Most Recently Shared on June 4, 2010 at 5:44 pm By:
Byetta Pen Drips: I am new to TuDiabetes. I have been on Metformin for a few years & last December my Dr put... http://bit.ly/a6V23s #dblog
BYETTA Approved For Expanded Use As First-Line Treatment For Type 2 Diabetes
medicalnewstoday.com — “Amylin pharmaceuticals, inc., (nasdaq: amln) and eli lilly and company (nyse: lly) announced that the u.s. food and drug administration (fda) has approved an expanded indication for byetta® (” View full resource at medicalnewstoday.com
Most Recently Shared on October 31, 2009 at 12:12 pm By:
BYETTA Approved For Expanded Use As First-Line Treatment For Type 2 Diabetes: Amylin Pharmaceuticals, Inc., (Na.. http://bit.ly/FO6jd
FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
fda.gov — “The U.S. Food and Drug Administration today acted on new safety information about possible kidney function problems, including kidney failure, in patients taking Byetta (exenatide), a drug used to treat Type 2 diabetes.” View full resource at fda.gov
Most Recently Shared on November 2, 2009 at 8:19 pm By:
FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems. Read the press release here: http://tinyurl.com/yfmgmf9
Eli Lilly and Company - BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
newsroom.lilly.com — “Eli Lilly and Company - BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes” View full resource at newsroom.lilly.com
Most Recently Shared on November 1, 2009 at 3:10 pm By:
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes - http://bit.ly/3SxCxX
Eli Lilly and Company - Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin
investor.lilly.com — “Eli Lilly and Company - Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin” View full resource at investor.lilly.com
Most Recently Shared on December 23, 2010 at 1:29 pm By:
Lilly and Amylin file sNDA for Byetta seeking expansion of indication http://ow.ly/3tEr9
Supplemental NDA submitted for Byetta for add-on therapy to insulin - MPR
empr.com — “Amylin Pharmaceuticals and Eli Lilly and Company announced that a supplemental New Drug Application (sNDA) has been submitted to the FDA for the expanded use of Byetta (exenatide) injection as an add-on therapy to basal insulin, with or without metformin and/or a thiazolidinedione (TZD) in conjunction with diet and exercise for adults with type 2 diabetes who are not achieving adequate glycemic control.” View full resource at empr.com
Most Recently Shared on December 23, 2010 at 6:23 pm By:
MPR News: Supplemental NDA submitted for Byetta for add-on therapy to insulin: Amylin Pharmaceuticals and Eli Li... http://bit.ly/dWyE1i
Amylin And Lilly Seek Expanded Byetta Approval - Drugs.com MedNews
drugs.com — “From Associated Press (December 22, 2010) Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said Wednesday they are asking the Food and Drug Administration to e” View full resource at drugs.com
Most Recently Shared on December 23, 2010 at 4:07 pm By:
Amylin And Lilly Seek Expanded Byetta Approval: From Associated Press (December 22, 2010) NEW YORK -- Eli... http://bit.ly/f6aBAT #drug
No pancreatitis risk seen in Byetta, Januvia drugs: NEW YORK (Reuters) - Two widely used diabetes medicines, Januv... http://bit.ly/bd2VYt
reuters.com — “No pancreatitis risk seen in Byetta, Januvia drugs: NEW YORK (Reuters) - Two widely used diabetes medicines, Januv... http://bit.ly/bd2VYt” View full resource at reuters.com
Most Recently Shared on June 28, 2010 at 11:25 pm By:
No pancreatitis risk seen in Byetta, Januvia drugs: NEW YORK (Reuters) - Two widely used diabetes medicines, Januv... http://bit.ly/bd2VYt
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
a diabetes community
A nonprofit social network with nearly 20K members touched by diabetes run by @DiabetesHF. Some tweets: FC (Fabiana Couto), MH (Manny Hernandez).
-
MediGuard.org
Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
Advertisement

